T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. (Q36297606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Roy Noy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Malka Eppel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Maya Haus-Cohen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Orian Mekler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yaeil Michaeli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Galit Denkberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yoram Reiter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

523-536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

Human tumor antigens recognized by T lymphocytes

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Design and evaluation of antigen-specific vaccination strategies against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Tracking T cells with tetramers: new tales from new tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Vaccination with T cell-defined antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Shedding light on immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Immunotherapy: bewitched, bothered, and bewildered no more

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Directed evolution of a stable scaffold for T-cell receptor engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Major histocompatibility complex conformational epitopes are peptide specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Peptide variants reveal how antibodies recognize major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Biotechnological applications of phage and cell display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Recombinant immunotoxins for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Targeted cytokines for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Improving antibody affinity by mimicking somatic hypermutation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Recent developments in MHC-class-I-mediated antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Structural basis of T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

Correctly Folded T-cell Receptor Fragments in the Periplasm of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.3.523

21 January 2018

Identifiers

DOI

10.1586/14737140.5.3.523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16250828%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference